FDA Monthly Preview: Key May Decisions to Watch

• by Kathryn Wighton

• April 29, 2026

FDA Monthly Preview: Key August Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• July 30, 2026

• 5 min

FDA approves oral dermatomyositis therapy

Phase 3 findings show improvements in physical function and skin disease activity.

• by Kathryn Wighton

• August 28, 2026

• 2 min

FDA Approves At-Home Starting Dose for Lecanemab

Patients may begin lecanemab-irmb treatment at home through self-administration or administration by a caregiver, according to the FDA.

• by Kathryn Wighton

• July 13, 2026

• 3 min